Mandeg, Jennie L.
HRN: 23-14-15 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/01/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/01/2023
06/08/2023
IV
900 Mg
Every 8 Hours
Breast Abscess
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes